Skip to main content

Table 1 Demographic data of the patients with severe imported malaria

From: Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals

Parameters

All (n = 110)

Gender

 

 Male (%)

 Female (%)

76 (69.1)

34 (30.9)

Age (years)

 

 Median age (IQR)

 Age ≤ 18 years (%)

 Age ≥ 60 years (%)

38.5 (23.8–57)

22 (20)

21 (19.1)

Weight (kg)

 

 Median weight (IQR)

71 (59–90)

Malaria acquisition region

 

 Western africa (%)

 Central Africa (%)

 East Africa (%)

 North Africa (%)

 Non-african (%)

71 (64.5)

34 (31.0)

3 (2.7)

1 (0.9)

1 (0.9)

Chemoprophylaxis

 

 No (%)

 Yes but incomplete (%)

 Yes (%)

 Unknown (%)

86 (78.2)

16 (14.5)

6 (5.5)

2 (1.8)

Time from return and onset of symptoms (days)

 

 Median time (IQR)

 ≤ 3 (%)

 4–7 (%)

 > 7 (%)

 Missing data (%)

9 (4.5–15)

24 (21.8)

26 (23.6)

59 (53.6)

1 (1.0)

Plasmodium type

 

Falciparum (%)

Ovale (%)

Vivax (%)

107 (97.3)

2 (1.8)

1 (0.9)

Malaria infection history

 

 Primary infection (%)

 Reinfection (%)

 Missing data (%)

88 (80)

21 (19.1)

1 (0.9)